7:45-8:45 a.m.
Tips and Tricks for a Successful Transradial Program
Moderators: Mina Madan, Toronto, Ontario, Canada, and Thierry Lefèvre, Massy, France

Why Do We Need to Learn the Transradial Approach? - Tift Mann, Raleigh, N.C.

9-10:15 a.m.
Interventional Cardiology Highlights from ACC, ESC and TCT 2009
Moderators: Carlos E. Ruiz, Chicago, Ill. and Marie Morice, Massy, France

The 3 Most Important Findings in Structural Heart Disease Interventions: 2009 - Horst Sievert, Frankfurt, Germany

The 3 Most Important Findings in Endovascular Interventions: 2009 - Kenneth Rosenfield, Boston, Mass.

The 3 Most Important Trials in Progress and Their Potential Impact on Interventional Cardiology Practice Beyond 2009: - David Holmes, Rochester, Minn.

10:45 a.m.-Noon
PCI Complications and Challenges: Audience Case Review (Ask the Experts)
Moderator and Case Presenter: Harry Dauerman, Burlington, Vt.

Panel Discussion: David Holmes, Rochester, Minn. and Edward Terrien, Burlington, Vt.

2-3:15 p.m.
Challenges and Complications in PFO/ASD Closures (Ask the Experts)
Moderator and Case Presenter: Carlos E. Ruiz, Chicago, Ill.

Panel Discussion: Horst Sievert, Frankfurt, Germany, Ramon Quesada, Miami, Fla. and John Rhodes, Durham, N.C.

3:45-5 p.m.
Percutaneous, Surgical and Medical Management of Hypertrophic Obstructive CardiomyopathyThe Genetics of Hypertrophic Obstructive Cardiomyopathy - Christine E. Seidman, Boston, Mass.

Physiology and Medical Management - Mark Sherrid, New York, N.Y.

Risk Stratification and Treatment of Sudden Cardiac Death - William J. McKenna, London, United Kingdom

Percutaneous Septal Ablation - William H Spencer, Charleston, S.C.

Septal Myectomy and Mitral Valve Surgery - Nicholas Smedira, Cleveland, Ohio

3:45-5 p.m.
Improvement in Treatment Options for PCI Patients with ACS
Moderators: Philip Aylward, Adelaide, Australia and Judith Hochman, New York, N.Y.

What's New in our Understanding of Platelet Biology: Receptors, Genotypes and Resistance - Lisa K. Jennings, Memphis, Tenn.

Advances in Thienopyridines: New data with Clopidogrel and Prasurgrel - Stephen D Wiviott, Boston, Mass.

The Arrival of the First Oral Non-Thienopyridine ADP Blockers - Stefan K. James, Uppsala, Sweden

Benefits and Challenges with Intravenous Antiplatelet Agents: EARLY, CHAMPION and INNOVATE - Harvey White, Auckland, New Zealand

Beyond ADP Blockade: What's Next in Antiplatelet Therapy - Kenneth W Mahaffey, Durham, N.C.

5:30-6:45 p.m.
The NHLBI Dynamic Registry: A 30-Year Journey
Moderators: Spencer B. King, Atlanta, Ga., and David P. Faxon, Boston, Mass.

The Story of the NHLBI Registry: From the Perspective of the Clinician-Investigator - David O. Williams, Boston, Mass.

The Evolution of Coronary Intervention: Key Contributions of the Registry - Alice K Jacobs, Boston, Mass.

Keynote Address: The Prospective Observational Study: An Essential Research Tool - Eric D. Peterson, Durham, N.C.

View of the Parent: Comments from NHLBI - Michael J. Domanski, Bethesda, Md.